[1] Twelve years of European cancer drug approval-a systematic investigation of the 'magnitude of clinical benefit'

[2] Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment

[3] Treatment of metastatic non-small cell lung cancer: 2018 guidelines of the Italian Association of Medical Oncology (AIOM).

[4] Management of kidney cancer patients: 2018 guidelines of the Italian Medical Oncology Association (AIOM).